“…Nine present data for feasibility, acceptability, or outcomes from the evaluation of mHealth interventions ( Bauer et al, 2017 ; Bhatia et al, 2021 ; Bhuiyan et al, 2021 ; Knutson et al, 2021 ; Maharjan et al, 2021 ; Seshu et al, 2021 ; Silfee et al, 2021 ; Vigil-Hayes et al, 2021 ; Forman-Hoffman et al, 2023 ) and two are study protocols describing development, deployment, or evaluation of future mHealth interventions ( Arenas-Castañeda et al, 2020 ; Moffett et al, 2022 ). Of these eleven studies, six were conducted in the U.S. ( Bauer et al, 2017 ; Bhuiyan et al, 2021 ; Knutson et al, 2021 ; Silfee et al, 2021 ; Vigil-Hayes et al, 2021 ; Forman-Hoffman et al, 2023 ) while the others were conducted in Mexico ( Arenas-Castañeda et al, 2020 ), Canada ( Bhatia et al, 2021 ), Nepal ( Maharjan et al, 2021 ), South Africa ( Moffett et al, 2022 ), and India ( Seshu et al, 2021 ). All included user depression and anxiety symptoms among the problems they were designed to address.…”